Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Randy Scott, PhD, Executive Chairman, Genomic Health, talks about advances in genome-based testing and understanding of cancer. Filmed at FutureMed, in February, 2012, at Singularity University.
Amir Belson, MD, CTO, Neoguide Systems, discusses his invention of the Neoguide colonoscope. Filmed at FutureMed, in February, 2012, at Singularity University.
Dale Bredesen, MD, Professor & Founding President, Buck Institute, explains the model of Alzheimer’s Disease as a prion loop disorder, and the implications of that model for future…
Jeremy Bailenson, Director, Virtual Human Interaction Lab, Stanford University, talks about the power of virtual reality technology to effect behavioral change, especially in the challenging area of lifestyle…
Author Sonia Arrison, MA, talks about the implications of relatively inexpensive, widely available genome sequencing, which she says is not far off. Filmed at FutureMed, in February, 2012, at Singularity…
Jeremy Bailenson, Director, Virtual Human Interaction Lab, Stanford University, talks about the power of virtual reality technology to effect behavioral change, especially in the challenging area of lifestyle…